SOUTH SAN FRANCISCO, Calif., May 2, 2014 /PRNewswire/ -- Second Genome announced today that it has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic disease. The goal...